BJ
NKTR icon

BlackRock Japan’s Nektar Therapeutics NKTR Stock Holding History

BlackRock Japan’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$16K Buy
85
+45
+113% +$9.15K ﹤0.01% 1163
2016
Q3 		$10K Buy
+40
New +$10.3K ﹤0.01% 1205
2014
Q2 		– Sell
-250
Closed -$45K – 1364
2014
Q1 		$45K Buy
+250
New +$49.5K ﹤0.01% 1176

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's NKTR Position: Q4 2016 in Review

BlackRock Japan increased its Nektar Therapeutics (NKTR) stake by 113% in Q4 2016, buying an estimated $9.15K and bringing the position to 85 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #1163.

BlackRock Japan first reported a position in NKTR in Q1 2014 and has held it in 3 quarters since. The position peaked at $45K in Q1 2014. 199 funds tracked by Wall St. Rank hold NKTR as of Q4 2016.

  • BlackRock Japan held 85 shares of Nektar Therapeutics worth $16K as of Q4 2016.
  • BlackRock Japan bought 45 Nektar Therapeutics shares in Q4 2016, an estimated $9.15K.
  • Nektar Therapeutics made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1163 holding.
  • BlackRock Japan first reported a position in Nektar Therapeutics in Q1 2014 and has held it in 3 quarters since.
  • BlackRock Japan's Nektar Therapeutics position peaked at $45K in Q1 2014.
  • 199 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.